Journals / Sakarya Tıp Dergisi / 2026 / Volume: 15 Issue: 1

Does Oxidative Stress Promote The Effect of The Paraoxonase Enzyme Family (PON) On Cancer? A Review Study to Clarify This Relationship by PONs

Oksidatif Stres Paraoksonaz Enzim Ailesinin (PON) Kanser Üzerindeki Etkisini Arttırır mı? PON Ailesinin Oksidatif Stres ve Kanser İlişkisinin İncelenmesini Amaçlayan Bir Derleme

Pages
756–765
Publication Date
2022-12-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review focuses on specific changes that affect the DNA molecule, and signaling pathways, and regulate the various cancers through the attraction of PON, an enzyme for degrading lipid peroxides within the cell as well as lipoproteins in the bloodstream.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cancer development and progression are associated with oxidative stress.
📊
Key Findings & Data:The human enzyme paraoxonase (PON) contributes to antioxidant metabolism and decreased antioxidant levels.
💡
Conclusion & Impact:This review focuses on specific changes that affect the DNA molecule, and signaling pathways, and regulate the various cancers through the attraction of PON, an enzyme for degrading lipid peroxides within the cell as well as lipoproteins in the bloodstream.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:PON · kanser · antioksidan

Abstract

Cancer development and progression are associated with oxidative stress. Oxidative stress can favor high concentrations of reactive oxygen species (ROS), and free radicals are associated with antioxidant metabolism. The human enzyme paraoxonase (PON) contributes to antioxidant metabolism and decreased antioxidant levels. This leads to a high-risk factor for coronary heart disease. This review focuses on specific changes that affect the DNA molecule, and signaling pathways, and regulate the various cancers through the attraction of PON, an enzyme for degrading lipid peroxides within the cell as well as lipoproteins in the bloodstream.

Özet

Kanser gelişimi ve ilerlemesi oksidatif stres ile ilişkilidir. Yüksek seviyelerde reaktif oksijen türleri (ROS) ve serbest radikaller, fizyolojik bir durum olan oksidatif strese neden olmaktadır. Oksidatif strese karşı geliştirilen antioksidan metabolizması çok önemlidir. Antioksidan seviyelerindeki azalma, koroner kalp hastalıklarının risk faktörleri arasında sayılabilir. Paraoksonaz enzimi (PON), kan dolaşımındaki lipoproteinlerin yanı sıra hücre içindeki lipid peroksitlerini de parçalayarak antioksidan metabolizmanın devreye girmesine sebep olmakta ve düşük seviylerdeki antioksidanlar koroner kalp hastalığinda etkili bir risk faktörü haline gelebilmektedir. Bu derleme, önemli bir antioksidan enzim olan PON’un; DNA hasarı, çeşitli kanser türlerinin progresyonu ve sinyal yolaklarındaki değişiklikler ve lipoproteinler ile ilişkisi üzerindeki rollerine odaklanmaktadır.

🔖

Cite This Article

UYSAL, T. K., ÖRNEK, M., GÜLER, Ö. Ö. (2022). Does Oxidative Stress Promote The Effect of The Paraoxonase Enzyme Family (PON) On Cancer? A Review Study to Clarify This Relationship by PONs. Sakarya Tıp Dergisi, Volume: 15 Issue: 1, 756–765. https://ajindex.com/articles/862874

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Shakunthala N. New cytochrome P450 mechanisms: implications of understanding the molecular basis for drug toxicity at the level of the cytochrome. Expert opinion on drug metabolism & toxicology 2010; 6(1): 1-15
  2. Bacchetti T, Ferretti G, Sahebkar A. The role of paraoxonase in cancer. Seminars in Cancer Biology; 2019: Elsevier; 2019. p. 72-86
  3. Reichert CO, Levy D, Bydlowski SP. Paraoxonase Role in Human Neurodegenerative Diseases. Antioxidants 2021; 10(1): 11
  4. Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, et al. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arteriosclerosis, thrombosis, and vascular biology 2001; 21(4): 542-7
  5. Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. The paraoxonase gene family and atherosclerosis. Free Radical Biology and Medicine 2005; 38(2): 153-63
  6. Demirel T, Yaylim I, Ergen HA, Gunay MK, Tekant Y, Isbir T. Association of paraoxonase (PON1) polymorphisms and activity with colorectal cancer predisposition. Biotechnology Biotechnological Equipment 2021; 35(1): 232-8
  7. Mackness B, Mackness M. Anti-inflammatory properties of paraoxonase-1 in atherosclerosis. Paraoxonases in Inflammation, Infection, and Toxicology: Springer; 2010: 143-51
  8. Rosenblat M, Gaidukov L, Khersonsky O, Vaya J, Oren R, Tawfik DS, et al. The catalytic histidine dyad of high-density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low-density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. Journal of Biological Chemistry 2006; 281(11): 7657-65
  9. Manco G, Porzio E, Carusone TM. Human Paraoxonase-2 (PON2): Protein Functions and Modulation. Antioxidants (Basel) 2021; 10(2)
  10. Grdic Rajkovic M, Rumora L, Barisic K. The paraoxonase 1, 2 and 3 in humans. Biochemia medica: Biochemia medica 2011; 21(2): 122-30
  11. Furlong CE, Marsillach J, Jarvik GP, Costa LG. Paraoxonases-1,-2 and-3: what are their functions? Chemical-biological interactions 2016; 259: 51-62
  12. Milani P, Ambrosi G, Gammoh O, Blandini F, Cereda C. SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration. Oxidative medicine and cellular longevity 2013; 2013
  13. Saeidnia S, Abdollahi M. Toxicological and pharmacological concerns on oxidative stress and related diseases. Toxicology and applied pharmacology 2013; 273(3): 442-55
  14. Bozan